0001078782-16-003807.txt : 20161115 0001078782-16-003807.hdr.sgml : 20161115 20161115140010 ACCESSION NUMBER: 0001078782-16-003807 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161115 DATE AS OF CHANGE: 20161115 EFFECTIVENESS DATE: 20161115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PixarBio Corp CENTRAL INDEX KEY: 0001623077 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEMBERSHIP SPORTS & RECREATION CLUBS [7997] IRS NUMBER: 471945113 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-204070 FILM NUMBER: 161999062 BUSINESS ADDRESS: STREET 1: 200 BOSTON AVENUE, SUITE 1875 CITY: MEDFORD STATE: MA ZIP: 02155 BUSINESS PHONE: (617) 803-8838 MAIL ADDRESS: STREET 1: 200 BOSTON AVENUE, SUITE 1875 CITY: MEDFORD STATE: MA ZIP: 02155 FORMER COMPANY: FORMER CONFORMED NAME: BMP Holdings Inc. DATE OF NAME CHANGE: 20141022 NT 10-Q 1 nt10q093016_nt10q.htm FORM 12B25 NOTICE OF LATE FILING Form 12b25 Notice of Late Filing


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

NOTIFICATION OF LATE FILING

 

(Check One):         . Form 10-K         . Form 20-F         . Form 11-K     X . Form 10-Q         . Form 10-D         . Form N-SAR         . Form N-CSR

 

For Period Ended:   September 30, 2016

 

      . Transition Report on Form 10-K

      . Transition Report on Form 20-F

      . Transition Report on Form 11-K

      . Transition Report on Form 10-Q

      . Transition Report on Form N-SAR

     For the Transition Period Ended:_____________________________________

  

Read Instructions (on back page) Before Preparing Form. Please Print or Type.

 

NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION
HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.

  

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: ________

 

 

PART I -- REGISTRANT INFORMATION

  

Full Name of Registrant: 

Pixarbio Corporation 

 

Former Name if Applicable 

N/A

  

Address of Principal Executive Offices (Street and Number) 

200 Boston Ave., Ste. 1875, Medford, MA 02155


PART II - RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed (Check box if appropriate)

 

  X .

(a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

 

 

  X .

(b)  

The subject quarterly report on Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date; and

 

 

 

 

(c)

The accountant's statement or other exhibit required by Rule 12(b)-25(c) has been attached if applicable.




  

PART III -- NARRATIVE

 

State below in reasonable detail the reasons why the Form 10-Q could not be filed within the prescribed time period. (Attach Extra Sheets If Needed)

  

The Registrant could not complete the required financial statements within the prescribed filing date without unreasonable effort and expense.

 

PART IV --OTHER INFORMATION

 

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this notification:

 

Francis M. Reynolds

(617)

803-8838

Name

Area Code

Telephone Number

 

(2)  Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s).

  X . Yes         . No

  

(3)  Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

      . Yes     X . No


If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

PIXARBIO CORPORATION

(Name of Registrant as Specified in Charter) 


has caused this notification to be signed on their behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

Date  November 15, 2016      

By:

/s/  Francis M. Reynolds

 

 

 

Francis M. Reynolds, Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

Instruction: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.

 

 

-----------------------------------ATTENTION------------------------------------

INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL

VIOLATIONS (SEE 18 U.S.C. 1001).